Bottle true to moonshine's roots

Profiled on reality show “Moonshiners,” Tim Smith’s Climax Moonshine whiskey goes legit, launching in a bottle that reflects his unique story and the culture of moonshining.

Pw 60628 Climax Bottles 3 Angles

To bring Discovery Channel reality star Tim Smith’s moonshine beyond it’s Climax, VA, roots and to the retail market, Beardwood&Co. has developed packaging that speaks to Smith’s backwoods moonshine-making experience. Smith has gained fame in the show, “Moonshiners,” which tells the stories of “shiners” who still engage in the age-old illegal practice of distilling whiskey.

Making Smith’s whiskey legit, Prost Beverage Co., Fort Pierce, FL, licensed the rights in 2013 to develop a legal moonshine brand faithful to Smith’s recipe of pot-distilled corn, rye, and barley malt mash for a 90-proof spirit under the Climax name. To convey the authenticity of the brand through packaging, Beardwood called on aspects of Smith’s life as well as elements that harken back to the handcrafted nature of moonshine.

“First and foremost, Tim wanted to make sure that the brand represented him and his recipe in an authentic way,” says Beardwood Senior Brand Strategist Sadie Dyer. “There are three generations of moonshine-making experience in every bottle, and we needed to portray that. But he also realized that the shelf is crowed, and Tim wanted to ensure that the packaging would be noticeable among the competition and draw you in from several feet away.”

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?